跳至主要内容
临床试验/NCT06031025
NCT06031025招募中不适用

Prospective Assessment of the Prevalence and Natural History of Gastroesophageal Reflux and Functional Gastro-intestinal Disorders Among At-risk Infants

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 个研究点 分布在 1 个国家目标入组 71 人开始时间: 2022年5月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
71
试验地点
1
主要终点
Prevalence of FGID

研究概览

简要总结

The goal of this observational study is to learn about the prevalence and characteristics of functional gastrointestinal disorders (FGID) in at risk infants (former preterm infants and those with birth asphyxia) during the first 2 years of life. The main questions it aims to answer are:

  • evaluate the prevalence of symptoms related to gastro-esophageal reflux (GER), of functional gastrointestinal disorders during the first 2 years of life
  • describe growth parameters during follow-up up to the corrected age of 2 years Participants will be assessed clinically and with a structured questionnaire based on the Rome IV criteria to describe FGID.

详细描述

Infants will undergo clinical assessment at 3, 6, 12, 24 months' corrected age at the local Follow-up clinic.

Clinical examination, anthropometric measurement and data from a structured questionnaire to detect FGID will be performed.

Z-scores for weight, length and head circumference will be calculated according to the World Health Organization (WHO) standards.

Data from the questionnaires will be collected. Clinical characteristics of patients and perinatal data will be collected and analyzed by appropriate statistical methods.

The prevalence and characteristics of FGID in the study population will be compared to published data (mostly from term infants).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
3 Months 至 24 Months(Child)
性别
All
接受健康志愿者

入选标准

  • infants with gestational age at birth < 31 weeks
  • infants with gestational age at birth < 37 weeks and major respiratory or neurologic morbidity
  • infants with history of perinatal asphyxia

排除标准

  • lack of informed consent
  • diagnosis of congenital or other major gastrointestinal disease (i.e. inflammatory bowel disease, cancer)

结局指标

主要结局

Prevalence of FGID

时间窗: 3, 6, 12, 24 months of corrected age

Occurrence of FGID (percentage of patients)

Frequency of FGID

时间窗: 3, 6, 12, 24 months of corrected age

Frequency of FGID (i.e. number of symptoms per day)

Severity of FGID

时间窗: 3, 6, 12, 24 months of corrected age

Severity (scales from 0 to 10 for increasing values) of FGID

次要结局

  • Somatic growth: weight(3, 6, 12, 24 months of corrected age)
  • Somatic growth: head circumference(3, 6, 12, 24 months of corrected age)
  • Somatic growth: length(3, 6, 12, 24 months of corrected age)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验